Nuvation Bio Inc. (NUVB) DCF Valuation

Nuvation Bio Inc. (NUVB) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Nuvation Bio Inc. (NUVB) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial prospects of Nuvation Bio Inc. (NUVB) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to determine Nuvation Bio Inc. (NUVB) intrinsic value and inform your investment decisions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -32.1 -43.4 -89.3 -119.5 -99.6 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .1 .4 .5 .2 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -32.1 -43.6 -89.7 -120.0 -99.8 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 118.9 215.8 765.4 661.0 611.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 1.1 3.0 2.5 3.7
Account Receivables, % 100 100 100 100 100
Inventories .0 2.9 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 2.0 2.2 3.9 2.1 2.2 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.7 -.1 -.3 -.4 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -32.1 -41.3 -82.4 -102.1 -99.8 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -30.7 -45.2 -79.5 -103.2 -100.8 1.5 .0 .0 .0 .0
WACC, % 10.82 10.82 10.82 10.82 10.82 10.82 10.82 10.82 10.82 10.82
PV UFCF
SUM PV UFCF 1.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 1
Net Debt -39
Equity Value 40
Diluted Shares Outstanding, MM 219
Equity Value Per Share 0.18

What You Will Get

  • Real Nuvation Bio Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Nuvation Bio’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.

Key Features

  • Comprehensive Data: Nuvation Bio Inc.'s (NUVB) historical financial reports and pre-filled projections.
  • Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Observe the recalculation of Nuvation Bio Inc.'s (NUVB) intrinsic value instantly.
  • Intuitive Visualizations: Dashboard graphs showcase valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and financial professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based Nuvation Bio Inc. (NUVB) DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other key metrics.
  3. Instant Calculations: The model automatically recalculates Nuvation Bio Inc.’s intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the outcomes to inform your investment or financial decisions.

Why Choose Nuvation Bio Inc. (NUVB)?

  • Innovative Solutions: Leverage cutting-edge technology for advanced biopharmaceutical development.
  • Expert Team: Collaborate with industry leaders and experienced professionals in biotech.
  • Robust Pipeline: Benefit from a diverse range of therapeutic candidates targeting unmet medical needs.
  • Commitment to Quality: Adhere to the highest standards in research and development for reliable results.
  • Growth Potential: Invest in a company poised for significant advancements in the biopharmaceutical landscape.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Nuvation Bio Inc. (NUVB) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Nuvation Bio Inc. (NUVB).
  • Consultants: Deliver professional valuation insights on Nuvation Bio Inc. (NUVB) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Nuvation Bio Inc. (NUVB) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios, including Nuvation Bio Inc. (NUVB).

What the Template Contains

  • Pre-Filled DCF Model: Nuvation Bio Inc.'s (NUVB) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Nuvation Bio Inc.'s (NUVB) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.